Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
Abstract
The purpose of this paper was to investigate the effects of dapagliflozin in chronic kidney disease (CKD) patients, with and without heart failure (HF). Patients with CKD, with and without type 2 diabetes, were enrolled in the DAPA-CKD (Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease) trial. Some patients had HF at baseline. A total of 4,304 participants were randomized to dapagliflozin 10 mg daily or placebo. The...
Paper Details
Title
Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
Published Date
Nov 1, 2021
Journal
Volume
9
Issue
11
Pages
807 - 820
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History